Showing results (1-10 of 113) with videos related to
Sort By:
Pageof 12
Current Opinion in Virology|May 28, 2021
SARS-CoV-2 vaccines - the biggest medical research project of the 21st centuryDrishya Kurup, Matthias J SchnellHybridoma and Hybridomics|May 29, 2002
New approaches to the development of live attenuated rabies vaccinesBernhard Dietzschold, Matthias J SchnellCurrent Opinion in Virology|November 1, 2020
Rhabdoviruses as vectors for vaccines and therapeuticsGabrielle Scher, Matthias J SchnellJournal of Virology|November 12, 2010
Rabies virus (RV) glycoprotein expression levels are not critical for pathogenicity of RVChristoph Wirblich, Matthias J SchnellFrontiers in Bioscience (Scholar Edition)|May 31, 2011
MicroRNA-122: a therapeutic target for hepatitis C virus (HCV) infectionGiuseppe Nunnari, Matthias J SchnellExpert Review of Vaccines|August 9, 2003
New approaches to the prevention and eradication of rabiesBernhard Dietzschold, Milosz Faber, Matthias J SchnellThe Journal of Allergy and Clinical Immunology|May 26, 2022
Current vaccine strategies against SARS-CoV-2: Promises and challengesDrishya Kurup, Jacob Myers, Matthias J SchnellVirology|February 23, 2015
Reverse genetics of Mononegavirales: How they work, new vaccines, and new cancer therapeuticsChristian K Pfaller, Roberto Cattaneo, Matthias J SchnellAnnual Review of Medicine|October 1, 2016
Toward an Effective Ebola Virus VaccineRohan Keshwara, Reed F Johnson, Matthias J SchnellJournal of Neurovirology|April 5, 2005
The application of reverse genetics technology in the study of rabies virus (RV) pathogenesis and for the development of novel RV vaccinesMatthias J Schnell, Gene S Tan, Bernhard DietzscholdPageof 12